Responses
Regular and young investigator award abstracts
Cellular therapies
108 MCY-M11, a CAR-PBMC cell product transiently expressing a mesothelin targeted mRNA CAR, exhibits desirable functional and immune phenotype attributed to sustained antitumor immunity in vitro
Compose a Response to This Article
Other responses
No responses have been published for this article.
